Literature DB >> 19573807

Pancreatic cancer--could it be that simple? A different context of vulnerability.

Daniel D Von Hoff1, Ron Korn, Spyro Mousses.   

Abstract

In a recent issue of Science, Olive and colleagues document that inhibition of Hedgehog (Hh) signaling in a genetically engineered mouse model of pancreatic cancer can enhance the intratumor concentration of certain anticancer drugs. Could this finding provide us with a new method to attack pancreatic cancer?

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19573807     DOI： 10.1016/j.ccr.2009.06.011

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  14 in total

Review 1.  When human cells meet bacteria: precision medicine for cancers using the microbiota.

Authors:  Han Zhang; Litao Sun
Journal:  Am J Cancer Res       Date:  2018-07-01       Impact factor: 6.166

Review 2.  Metastatic pancreatic cancer: Is there a light at the end of the tunnel?

Authors:  Vanja Vaccaro; Isabella Sperduti; Sabrina Vari; Emilio Bria; Davide Melisi; Carlo Garufi; Carmen Nuzzo; Aldo Scarpa; Giampaolo Tortora; Francesco Cognetti; Michele Reni; Michele Milella
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

3.  Radiosensitization and stromal imaging response correlates for the HIF-1 inhibitor PX-478 given with or without chemotherapy in pancreatic cancer.

Authors:  David L Schwartz; James A Bankson; Robert Lemos; Stephen Y Lai; Arun K Thittai; Yi He; Galen Hostetter; Michael J Demeure; Daniel D Von Hoff; Garth Powis
Journal:  Mol Cancer Ther       Date:  2010-06-29       Impact factor: 6.261

4.  Insights into the Role of microRNAs in Pancreatic Cancer Pathogenesis: Potential for Diagnosis, Prognosis, and Therapy.

Authors:  Mohammad Aslam Khan; Haseeb Zubair; Sanjeev Kumar Srivastava; Seema Singh; Ajay Pratap Singh
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

Review 5.  Therapeutic options for the management of pancreatic cancer.

Authors:  Maria L Rossi; Azeem A Rehman; Christopher S Gondi
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

6.  Human pancreatic cancer progression: an anarchy among CCN-siblings.

Authors:  Sushanta K Banerjee; Gargi Maity; Inamul Haque; Arnab Ghosh; Sandipto Sarkar; Vijayalaxmi Gupta; Donald R Campbell; Daniel Von Hoff; Snigdha Banerjee
Journal:  J Cell Commun Signal       Date:  2016-08-19       Impact factor: 5.782

7.  Combining clinicopathological predictors and molecular biomarkers in the oncogenic K-RAS/Ki67/HIF-1α pathway to predict survival in resectable pancreatic cancer.

Authors:  R Qin; T C Smyrk; N R Reed; R L Schmidt; T Schnelldorfer; S T Chari; G M Petersen; A H Tang
Journal:  Br J Cancer       Date:  2015-01-13       Impact factor: 7.640

8.  Stromal disrupting effects of nab-paclitaxel in pancreatic cancer.

Authors:  R Alvarez; M Musteanu; E Garcia-Garcia; P P Lopez-Casas; D Megias; C Guerra; M Muñoz; Y Quijano; A Cubillo; J Rodriguez-Pascual; C Plaza; E de Vicente; S Prados; S Tabernero; M Barbacid; F Lopez-Rios; M Hidalgo
Journal:  Br J Cancer       Date:  2013-08-01       Impact factor: 7.640

9.  Impact of SPARC expression on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: a pooled analysis from prospective clinical and translational trials.

Authors:  Steffen Ormanns; Michael Haas; Sibylle Baechmann; Annelore Altendorf-Hofmann; Anna Remold; Detlef Quietzsch; Michael R Clemens; Martin Bentz; Michael Geissler; Helmut Lambertz; Stephan Kruger; Thomas Kirchner; Volker Heinemann; Stefan Boeck
Journal:  Br J Cancer       Date:  2016-11-01       Impact factor: 7.640

Review 10.  Microbiome and pancreatic cancer: A comprehensive topic review of literature.

Authors:  Natalie Ertz-Archambault; Paul Keim; Daniel Von Hoff
Journal:  World J Gastroenterol       Date:  2017-03-14       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.